Content uploaded by Daniel Chu
Author content
All content in this area was uploaded by Daniel Chu on Aug 28, 2014
Content may be subject to copyright.
EmergingInfectiousDiseases•www.cdc.gov/eid•Vol.20,No.7,July2014 1231
MERS Coronavirus
in Dromedary
Camel Herd,
Saudi Arabia
Maged G. Hemida,1 Daniel K.W. Chu,1
Leo L.M. Poon, Ranawaka A.P.M. Perera,
Mohammad A. Alhammadi, Hoi-yee Ng,
Lewis Y. Siu, Yi Guan, Abdelmohsen Alnaeem,
and Malik Peiris
A prospective study of a dromedary camel herd during
the2013–14calving seasonshowedMiddle East respira-
tory syndrome coronavirus infection of calves and adults.
Viruswasisolatedfrom the nose andfeces but more fre-
quentlyfromthenose.Preexistingneutralizingantibodydid
not appear to protect against infection.
Ongoing transmission of Middle East respiratory syn-
drome coronavirus (MERS-CoV) to humans under-
scores the need to understand the animal sources of zoonot-
ic infection (1,2). MERS-CoV RNA has been detected in
dromedary camels (3,4), and dromedary infection precedes
human infection (5). We conducted a prospective study in
dromedary herds in Al-Hasa, Saudi Arabia, through the
peak calving season (December 2013–February 2014) to
document virologic features of MERS-CoV infection in
these animals.
The Study
We studied dromedaries at 2 farms in Al-Hasa, 4–5
km apart. Farm A had 70 animals; 4 were 1 month of
age, 8 were ≈1 year of age, and the rest were adults (>2
years of age). The herd did not go to pasture in the des-
ert (“zero-grazing”; type of grazing may inuence types
of potential exposures). The animals were sampled on 5
occasions during November 2013–February 2014. Farm
B (“semi–zero-grazing”) had 17 adults and 3 calves; its
herd was sampled in February 2014. Nasal, oral, or rectal
swab samples and blood samples were collected (Table 1;
online Technical Appendix Table, http://wwwnc.cdc.gov/
EID/article/20/7/14-0571-Techapp1.pdf). Swab and serum
samples were stored frozen at −80°C until testing.
Hydrolysis probe–based real-time reverse transcrip-
tion PCR (RT-PCR) targeting MERS-CoV upstream of
E (UpE) and open reading frame (ORF) 1a genes and a
broad-range RT-PCR reacting across the CoV family to
detect other CoVs were used as described (4). Specimens
initially positive for MERS-CoV were re-extracted and re-
tested to conrm the positive results.
The full genome of MERS-CoV was obtained directly
from the clinical specimens with 3–4 times coverage by se-
quencing PCR amplicons with overlapping sequence reads
and sequence assembly (4). Dromedary MERS-CoV full
genomes obtained in this study (GenBank accession nos.
KJ650295–KJ650297) were aligned with human MERS-
CoV genomes retrieved from GenBank. We constructed
full-genome phylogenies using MEGA5 with neighbor-
joining and bootstrap resampling of 500 replicates (6).
Virus isolation was attempted in Vero E6 cells. We tested
serum samples for neutralizing antibody titers using a vali-
dated MERS-CoV spike pseudoparticle neutralization test
(7) (online Technical Appendix).
At farm A, we detected MERS-CoV in 1 of 4 drom-
edaries sampled on November 30, none of 11 sampled on
December 4, nine of 11 sampled on December 30, and none
of 9 sampled on February 14 (Table 1). Of the 10 drom-
edaries that tested positive for MERS-CoV, 9 had parallel
nasal and fecal specimens tested, with virus detected in the
nasal swab specimens from 8 and the fecal specimen from
1. At the December 30 sampling, 7 of 8 calves and 2 of 3
adults tested positive for MERS-CoV, indicating that when
MERS-CoV circulates on a farm, both calves and adults
can be infected (online Technical Appendix Table). Be-
cause all 12 adults with serum collected before December
30 were seropositive (titers >320), it is likely, though not
certain, that the MERS-CoV infections in the 2 adults (nos.
21, 19Dam) sampled on December 30 were reinfections,
as has been reported for other CoVs (8). The seronegative
1-year-old calves, nos. 13 and 14, had the highest nasal vi-
ral loads (UpE assay 1.3 × 108 to 1.78 × 108/mL specimen),
and a 2-week-old calf, no. 22, with (presumably passively
acquired) titers of 1,280 became infected but had a much
lower viral load. Overall, these data suggest that prior in-
fection or passively acquired maternal antibody might not
provide complete protection from infection (online Techni-
cal Appendix Table).
Four MERS-CoV–positive calves had mild respiratory
signs (cough, sneezing, respiratory discharge), abnormally
elevated body temperature, and loss of appetite at the De-
cember 30 sampling, which resolved over a few days. Three
calves from which paired serum samples were available
(Table 2; nos. 13, 15, 17) demonstrated >4-fold rising anti-
body titers to MERS-CoV. Calf no. 13 (1 year of age) had
Author afliations: King Faisal University,Al Hofuf, Saudi Arabia
(M.G. Hemida, M.A. Alhammadi, A. Alnaeem); Kafrelsheikh
University,KafrElsheikh,Egypt(M.G.Hemida);andTheUniversity
of Hong Kong, Hong Kong, China (D.K.W. Chu, L.L.M. Poon,
R.A.P.M.Perera,H.-y.Ng,L.Y.Siu,Y.Guan,M.Peiris)
DOI:http://dx.doi.org/10.3201/eid2007.140571 1These authors contributed equally to this article.
DISPATCHES
1232 EmergingInfectiousDiseases•www.cdc.gov/eid•Vol.20,No.7,July2014
a high viral load and was seronegative at the rst MERS-
CoV–positive result (indicating that it had been recently
infected) but was MERS-CoV RNA negative 6 weeks
later, suggesting that virus shedding is not prolonged. We
did not detect virus RNA by RT-PCR in the 3 acute-phase
serum samples from infected dromedaries (nos. 1, 16, 17),
suggesting that acute infection is not associated with pro-
longed viremia. Dromedaries from farm B were sampled
once on February 11; all results were negative.
The full genomes of MERS-CoV sequenced directly
from a nasal swab specimen collected on November 30
were identical to those from a nasal swab specimen and a
fecal specimen collected on December 30. In addition, the
complete spike gene was sequenced from 4 other MERS-
CoV–positive nasal swab specimens, and these spike genes
were genetically identical.
Virus isolation in Vero E6 cells was attempted from
7 positive nasal swab and fecal specimens that had >106
copies/mL in the original sample in the UpE RT-PCR. Vi-
ruses were isolated from 2 nasal swab (nos. 13, 14) and
1 fecal swab (no. 19Dam) specimens collected on De-
cember 30; these were the specimens with high numbers
of MERS-CoV copies (9.27 × 107 to 1.78 × 108 copies/
mL). The full-genome sequence of 1 virus culture isolate
was obtained in parallel with that of the original virus in
the original clinical specimen. We observed 3 nucleotide
changes in ORF1b, spike, and membrane protein genes
in the isolates after 2 passages in Vero E6 cells, of which
2 were nonsynonymous, leading to changes in spike
(S1251F) and membrane proteins (T8I). This nding
highlights the importance of sequencing the viral genome
directly from clinical specimens.
MERS-CoVs circulating in dromedaries on farm A
during a 1-month period were genetically identical over the
full 30,100-nt genome in 3 viruses and the spike protein of
4 more viruses, giving a mutation rate of 0 nt substitutions
per site per day (95% credible interval 0 to 2.7 × 10−6). The
estimated mutation rate for epidemiologically unlinked hu-
man MERS-CoV was 3.1 × 10−6 (95% CI 2.4 × 10−6 to 3.8
× 10−6) (9).
Conclusions
The unusual genetic stability of MERS-CoV in
dromedaries, taken together with its high seroprevalence
(7,10–13), raises the hypothesis that dromedaries might be
the natural host for this virus. Further longitudinal stud-
ies of MERS-CoVs in dromedaries are needed to conrm
this hypothesis.
Genome organization of the dromedary MERS-CoV
detected in this study was identical to that of the virus in
humans. The virus strains clustered phylogenetically with-
in clade B (9) and were most closely related to the strain
MERS-CoV_FRA/UAE and to MERS-CoV detected in
Buraidah (Saudi Arabia) and Al-Hasa (Figure). The farm
is ≈300 km from United Arab Emirates and 600 km from
Buraidah. Dromedaries move between Al-Hasa and Burai-
dah and, more limitedly, between Al-Hasa and United
Arab Emirates.
The full-genome sequence of MERS-CoV from drom-
edaries in this study is 99.9% similar to genomes of hu-
man clade B MERS-CoV. The spike gene is the major
determinant for virus host specicity. In comparison with
other publically available human MERS-CoV sequences,
we found 6-nt mutations in the spike gene unique to these
dromedary viruses. Of these, 3 (S457G, L773F, and V810I)
were nonsynonymous. These amino acid changes are lo-
cated outside the binding interface between MERS-CoV
spike protein and human DPP4 receptor, suggesting these
amino acid differences are unlikely to affect receptor bind-
ing. Thus, these dromedary viruses may retain capacity
to infect humans, as Chu et al. suggested for dromedary
MERS-CoV in Egypt (4).
MERS-CoV may be isolated from nasal swab speci-
mans and feces, indicating that both could be possible sourc-
es of virus transmission to humans and other animals, but
virus detection rates were higher in nasal swab specimens.
Table 1. RT-PCRofdromedarycamelsamplesforMERS-CoV,
Al-Hasa, Saudi Arabia*
Farm,samplingdate
Age†/no.
sampled
No.specimens
positive/no.tested
Nasal Oral Fecal
FarmA
2013Nov30
Calf, 0
ND
ND
ND
Adult, 4 1/1 0/2 0/4
2013Dec4
Calf, 9
ND
0/9
0/7
Adult,2
ND
0/2
0/2
2013Dec30
Calf,8
7/8
0/1
0/6
Adult, 3
1/3‡
0
1/3‡
2014Feb14 Calf,7 0/7 ND 0/7
Adult,2
0/2
ND
0/2
FarmB:2014Feb11 Calf, 3 0/3 ND 0/3
Adult, 3
0/3
ND
0/3
*Data on individual d romedaries are providedinonlineTechnicalAppendix
Table, http://wwwnc.cdc.gov/EID/article/20/7/14-0571-Techapp1.pdf. RT-
PCR,reversetranscriptionPCR;MERS-CoV,MiddleEastrespiratory
syndromecoronavirus;ND,notdone.
†Adults are 6–14yofage;calvesare40dto2yofage.
‡Two different dromedaries were positive in nasal and fecal swabs.
Table2.LongitudinalsamplingofMERS-CoV–positive dromedary
camel calves on farm A, Al-Hasa, Saudi Arabia*
Calf no.
Sample collection
date
Sex/age
RT-PCR
result
Titer
13 2013Dec30 F/1y Positive <20
2014Feb14
F/1y
Negative
640
15
2013Dec30
F/1y
Positive
20
2014Feb14 F/1y Negative 160
17
2013Dec30
F/40d
Positive
80
2014Feb14 F/3mo Negative 1,280
19
2013Dec30
F/1y
Positive
NA
2014Feb14
F/1y
Negative
320
*MERS-CoV,MiddleEastrespiratorysyndromecoronavirus;RT-PCR,
reverse transcription PCR.
EmergingInfectiousDiseases•www.cdc.gov/eid•Vol.20,No.7,July2014 1233
MERS-CoVinCamelHerd
Our preliminary data suggest that preexisting MERS-CoV
antibody might not completely protect against re-infection;
however, this question needs more investigation.
We thank the King Faisal University Deanship of Scientif-
ic Research for their support (grant no. 143011). This research
was funded by a research contract from the National Insti-
tute of Allergy and Infectious Diseases, National Institutes of
Health (contract no. HHSN266200700005C), and a grant
from the European Community Seventh Framework Program
(FP7/2007-2013) under project European Management Platform
for Emerging and Re-emerging Disease entities (grant agreement
no. 223498) (EMPERIE).
Dr Hemida is an assistant professor of molecular virology at
King Faisal University, Saudi Arabia. His primary research inter-
ests are virus–host interactions and the molecular biology of CoVs.
References
1. World Health Organization. Middle East respiratory syndrome
coronavirus (MERS‐CoV). Summary and literature update—as of
27 March 2014 [cited 2014 Apr 11]. http://www.who.int/csr/disease/
coronavirus_infections/MERS_CoV_Update_27_March_2014.
pdf?ua=1
2. The WHO MERS-CoV Research Group. State of knowledge and
data gaps of Middle East respiratory syndrome coronavirus (MERS-
CoV) in humans. PLoS Curr. 2013;5:pii:ecurrents.outbreaks.0bf719
e352e7478f8ad85fa30127ddb8.
3. Alagaili AN, Briese T, Mishra N, Kapoor V, Sameroff SC, de Wit E,
et al. Middle East respiratory syndrome coronavirus infection in
dromedary camels in Saudi Arabia. MBio. 2014;5:e00884-14.
http://dx.doi.org/10.1128/mBio.01002-14
4. Chu DKW, Poon LLM, Gomaa MM, Shehata MM, Perera RA,
Zeid DA, et al. MERS coronaviruses in dromedary camels, Egypt.
[Internet]. Emerg Infect Dis. 2014 Jun [cited 2014 Mar 31].
5. Memish ZA, Cotton M, Meyer B, Watson SJ, Alsaha AJ,
Al Rabeeah AA, et al. Human infection with MERS corona-
virus after exposure to infected camels, Saudi Arabia, 2013.
[Internet]. Emerg Infect Dis. 2014. http://dx.doi.org/10.3201/
eid2006.140402
6. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S.
MEGA5: molecular eevolutionary genetics analysis using maxi-
mum likelihood, evolutionary distance, and maximum parsimony
methods. Mol Biol Evol. 2011;28:2731–9. http://dx.doi.org/10.1093/
molbev/msr121
7. Perera RA, Wang P, Gomaa MR, El-Shesheny R, Kandeil A,
Bagato O, et al. Seroepidemiology for MERS coronavirus using
microneutralisation and pseudoparticle virus neutralisation assays
reveal a high prevalence of antibody in dromedary camels in Egypt,
June 2013. Euro Surveill. 2013;18:20574.
8. Addie DD, Dennis JM, Toth S, Callanan JJ, Reid S, Jarrett O.
Long-term impact on a closed household of pet cats of natural
infection with feline coronavirus, feline leukaemia virus and feline
immunodeciency virus. Vet Rec. 2000;146:419–24. http://dx.doi.
org/10.1136/vr.146.15.419
9. Cotten M, Watson SJ, Zumla AI, Makhdoom HQ, Palser AL,
Ong SH, et al. Spread, circulation, and evolution of the Middle
East respiratory syndrome coronavirus. MBio. 2014;5:e01062-13.
http://dx.doi.org/10.1128/mBio.01062-13
10. Reusken CB, Haagmans BL, Müller MA, Gutierrez C, Godeke GJ,
Meyer B, et al. Middle East respiratory syndrome coronavirus
Figure. Phylogenetic tree of
Middle East respiratory syndrome
coronavirus (MERS-CoV) full
genomes (29,901 nt after trimming
the ends) or near–full genomes
from humans and dromedary
camels. The tree was constructed
by using neighbor-joining methods
with bootstrap resampling of 500
replicates. The most divergent
MERS-CoV,EgyptNRCE-HKU205,
was used as outgroup. Bold
type indicates camel MERS-CoV
genomes from this study. GenBank
accession numbers of genome
sequences included in this study are
KJ477102, KF600652, KF600630,
KF600651, KF186567, KF600627,
KF186564, KF600634, KF600632,
KF600644, KF600647, KF600645,
KF186565, KF186566, KF745068,
KF600620, KF600612, KC667074,
KC164505, KF192507, KF600613,
KF600628, KF961222, KF961221,
KC776174, and JX869059.
Scale bar indicates nucleotide
substitutions per site.
DISPATCHES
1234 EmergingInfectiousDiseases•www.cdc.gov/eid•Vol.20,No.7,July2014
neutralising serum antibodies in dromedary camels: a comparative
serological study. Lancet Infect Dis. 2013;13:859–66. http://dx.doi.
org/10.1016/S1473-3099(13)70164-6
11. Reusken CB, Ababneh M, Raj VS, Meyer B, Eljarah A,
Abutarbush S, et al. Middle East respiratory syndrome coronavirus
(MERS-CoV) serology in major livestock species in an
affected region in Jordan, June to September 2013. Euro Surveill.
2013;18:20662.
12. Hemida MG, Perera RA, Wang P, Alhammadi MA, Siu LY, Li M,
et al. Middle East respiratory syndrome (MERS) coronavirus
seroprevalence in domestic livestock in Saudi Arabia, 2010 to
2013. Euro Surveill. 2013;18:20659.
13. Meyer B, Müller MA, Corman VM, Reusken CB, Ritz D,
Godeke GJ, et al. Antibodies against MERS coronavirus in drom-
edary camels, United Arab Emirates, 2003 and 2013. Emerg Infect
Dis. 2014;20:552–9. http://dx.doi.org/10.3201/eid2004.131746
Address for correspondence; Malik Peiris, School of Public Health,
The University of Hong Kong, 21 Sassoon Rd, Pokfulam, Hong
Kong Special Administrative Region; email: malik@hku.hk; or
Abdelmohsen Alnaeem, Department of Clinical Studies, College of
Veterinary Medicine, King Faisal University, Saudi Arabia; email:
aaalnaeem@kfu.edu.sa